Lipopolysaccharide (LPS) Induces Matrix Metalloproteinase-2 and-9 (MMP-2 and MMP-9) in Bovine Dermal Fibroblasts

被引:0
|
作者
Akkoc, Ahmet [1 ]
Kahraman, M. Mufit [1 ]
Vatansever, Alper [1 ]
Gunaydin, Elcin [2 ]
Akdesir, Ezgi [1 ]
机构
[1] Uludag Univ, Fac Vet Med, Dept Pathol, TR-16059 Gorukle, Bursa, Turkey
[2] Vet Control Cent Res Inst, Breeding Dis Diag Lab, TR-06020 Ankara, Turkey
关键词
Bovine dermal fibroblast; Digital dermatitis; Immunoblotting; Lipopolysaccaride; Matrix metalloproteinase; STROMAL CELLS; EXPRESSION; MATRIX-METALLOPROTEINASE-9; INHIBITOR; HYPOXIA; CATTLE;
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Bovine digital dermatitis (BDD) is one of the most important problems in dairy herds. The exact etiology is unknown but it is believed that bacteria have cardinal roles. Matrix metalloproteinases (MMPs) are a group of enzymes responsible for the degradation of extracellular matrix proteins. The plausible role of these enzymes in the formation of ulcerative lesions in various tissues in humans is widely known. Ulcers on the plantar skin of hind feet are the prominent lesions in early stage of BDD. The main objective of this study was to determine whether MMP-2 and -9 enzymes are enhanced following LPS challenge in bovine dermal fibroblasts. Skin samples were obtained from two Holstein -Friesian cows after slaughtering. Primary bovine dermal fibroblasts were isolated from foot skin and then exposed to 5 g/ml LPS. As result, we found that LPS stimulates the release of MMP-2 and MMP-9 enzymes in bovine dermal fibroblasts. When compared with controls, immunoblots revealed significant increase in MMP-2 (by 56%, P<0.005) and MMP-9 (by 74%, P<0.005) enzymes. Zymographic analyses demonstrated LPS challenge resulted with the release of higher amount of active MMP-2 and 9 enzymes by 37% and 48%, respectively. These data indicate LPS may be an important factor in the pathogenesis of BDD by causing local MMP-2 and MMP-9 enzyme release. (C) 2015 PVJ. All rights reserved
引用
收藏
页码:189 / 193
页数:5
相关论文
共 50 条
  • [21] Matrix metalloproteinase (MMP)-2 and MMP-9 in seminal plasma
    Ioannis Tentes
    Byron Asimakopoulos
    Efthimia Mourvati
    Klaus Diedrich
    Safaa Al-Hasani
    Nikos Nikolettos
    Journal of Assisted Reproduction and Genetics, 2007, 24 : 278 - 281
  • [22] Gallic acid downregulates matrix metalloproteinase-2 (MMP-2) and MMP-9 in human leukemia cells with expressed Bcr/Abl
    Chen, Ying-Jung
    Chang, Long-Sen
    MOLECULAR NUTRITION & FOOD RESEARCH, 2012, 56 (09) : 1398 - 1412
  • [23] Captopril inhibits the matrix metalloproteinases: MMP-2 and MMP-9
    Williams, RN
    Dean, RA
    Parsons, SL
    Rowlands, BJ
    Watson, SA
    BRITISH JOURNAL OF CANCER, 2002, 86 : S17 - S17
  • [24] Overexpression of matrix metalloproteinase-2(MMP-2) and-9(MMP-9) in O-1N: Hamster squamous cell carcinoma cell line with high potential lymph node metastasis
    Zhang, YY
    Jinbu, Y
    Itoh, H
    Kusama, M
    Kikuchi, M
    Yashiro, T
    Mizukami, H
    Ozawa, K
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2004, 19 (04) : 541 - 541
  • [25] Matrix metalloproteinase (MMP-2 and MMP-9) and steroid receptor expressions in feline mammary tumors
    Akkoc, A.
    Inan, S.
    Sonmez, G.
    BIOTECHNIC & HISTOCHEMISTRY, 2012, 87 (04) : 312 - 319
  • [26] Gelatinases [Matrix metalloproteinase-2 (MMP-2) and MMP-9] induce carotid plaque instability but their systemic levels are not predictive of local events
    Tziakas, DN
    Lazarides, MK
    Tentes, IK
    Georgiadis, GS
    Eleftheriadou, E
    Chalikias, GK
    Kortsaris, A
    Hatseras, DI
    ANNALS OF VASCULAR SURGERY, 2005, 19 (04) : 529 - 533
  • [27] The significance of matrix metalloproteinase (MMP)-2 and MMP-9 in the ischemic stroke
    Kurzepa, Jacek
    Kurzepa, Joanna
    Golab, Piotr
    Czerska, Sara
    Bielewicz, Joanna
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2014, 124 (10) : 707 - 716
  • [28] Correlation between expression of matrix metalloproteinase-p (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma
    Kim, TS
    Kim, YB
    JOURNAL OF KOREAN MEDICAL SCIENCE, 1999, 14 (03) : 263 - 270
  • [29] Matrix metalloproteinase-2 (MMP-2) and-9 (MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) in differential diagnosis between low malignant potential (LMP) and malignant ovarian tumors
    Maatta, M.
    Talvensaari-Mattila, A.
    Turpeenniemi-Hujanen, T.
    Santala, M.
    EJC SUPPLEMENTS, 2006, 4 (12): : 24 - 25
  • [30] Matrix metalloproteinase-2 (MMP-2) and-9 (MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) in differential diagnosis between low malignant potential (LMP) and malignant ovarian tumours
    Maatta, Milla
    Talvensaari-Mattila, Anne
    Turpeenniemi-Hujanen, Taina
    Santala, Markku
    ANTICANCER RESEARCH, 2007, 27 (4C) : 2753 - 2758